Drug of choice in mixed mania is
**Core Concept**
Mixed mania is a condition where a patient experiences both manic and depressive symptoms simultaneously. The treatment of mixed mania involves stabilizing mood and reducing symptoms of mania and depression. In psychiatry, pharmacological interventions are crucial for managing these symptoms.
**Why the Correct Answer is Right**
Lithium is the preferred treatment for mixed mania due to its efficacy in stabilizing mood and reducing symptoms of mania and depression. Lithium works by inhibiting the reuptake of serotonin and norepinephrine, and also by blocking the sodium-potassium pump, which leads to an increase in intracellular sodium and a decrease in intracellular potassium. This ultimately results in the inhibition of the enzyme glycogen synthase kinase-3 (GSK-3), which plays a key role in the signaling pathways involved in mood regulation.
**Why Each Wrong Option is Incorrect**
**Option A:** Haloperidol is an antipsychotic medication that can be used to treat agitation and aggression in patients with mixed mania, but it is not the primary treatment for this condition.
**Option B:** Valproate is an anticonvulsant medication that can be used to treat mania and mood stabilization, but it is not the preferred treatment for mixed mania due to its side effect profile and potential for liver toxicity.
**Option C:** Quetiapine is an atypical antipsychotic medication that can be used to treat depression and mood stabilization, but it is not typically used as a first-line treatment for mixed mania.
**Clinical Pearl / High-Yield Fact**
It is essential to note that mixed mania is a complex condition, and treatment should be individualized based on the patient's symptoms and medical history. A thorough psychiatric evaluation and regular monitoring of the patient's response to treatment are crucial to ensure effective management of mixed mania.
**Correct Answer: C. Quetiapine is an atypical antipsychotic medication that can be used to treat depression and mood stabilization, but it is not typically used as a first-line treatment for mixed mania.